CapeVR is a tumour profiling service that curates, visualises and reports on variants—and helps to analyse the output from the CapeQ4 pipeline.
Our oncology services are transforming the way cancer is diagnosed and treated. CapeVR is a profiling service that provides clinicians with personalised treatment pathways for their patients based on their type of cancer.
The CapeVR service is cancer agnostic and can identify both rare and common cancers. Insights from whole genome analysis enable pathologists and clinicians to report on actionable variants, and match individuals to the latest possibilities for treatment.